All Opportunities

Confidential Project

Project Springboard

A U.S. profit-share interest tied to the anticipated first generic entry across a differentiated, device-enabled respiratory franchise.

Portfolio Sales
$2.4bn U.S.
Covered Products
$2.0bn
Projected Royalties
$248.7M
Launch
Late 2028
Project Springboard — Investment Teaser Open in New Tab Download

Loading the teaser… if it does not appear, use “Open in New Tab” or “Download” above.

Strictly confidential · Prepared by Intelligentzia Capital Management · Scroll within the frame to navigate pages

Discuss This Project

Explore Project Springboard

Contact our team to receive additional information under NDA.